In a filing, LB Pharmaceuticals Inc revealed its 10% Owner Deep Track Biotechnology Maste acquired Company’s shares for reported $30.0 million on Sep 12 ’25. In the deal valued at $15.00 per share,2,000,000 shares were bought. As a result of this transaction, Deep Track Biotechnology Maste now holds 2,686,138 shares worth roughly $54.9 million.
Then, Deep Track Biotechnology Maste bought 666,666 shares, generating $9,999,990 in total proceeds. Upon buying the shares at $15.00, the 10% Owner now owns 666,666 shares.
Before that, Pontifax Management 4 G.P. (20 bought 1,000,000 shares. LB Pharmaceuticals Inc shares valued at $15,000,000 were divested by the 10% Owner at a price of $15.00 per share. As a result of the transaction, Pontifax Management 4 G.P. (20 now holds 1,411,681 shares, worth roughly $28.85 million.
Stifel initiated its LB Pharmaceuticals Inc [LBRX] rating to a Buy in a research note published on October 06, 2025; the price target was $27. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early October with a ‘”an Overweight”‘ rating. Leerink Partners began covering LBRX with “an Outperform” recommendation on October 06, 2025.
Price Performance Review of LBRX
On Friday, LB Pharmaceuticals Inc [NASDAQ:LBRX] saw its stock fall -8.18% to $20.44. Over the last five days, the stock has lost -7.09%. Nevertheless, the stocks have fallen -8.18% over the past one year.
Levels Of Support And Resistance For LBRX Stock
The 24-hour chart illustrates a support level at 19.17, which if violated will result in even more drops to 17.91. On the upside, there is a resistance level at 22.17. A further resistance level may holdings at 23.91.
How much short interest is there in LB Pharmaceuticals Inc?
A steep rise in short interest was recorded in LB Pharmaceuticals Inc stocks on 2025-12-15, growing by 0.21 million shares to a total of 0.46 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.25 million shares. There was a rise of 46.22%, which implies that there is a positive sentiment for the stock.
